Prognostic/predictive markers in systemic therapy resistance and metastasis in breast cancer

Breast cancer is a highly heterogeneous group of diseases posing a significant challenge in biomarker-driven research and the development of effective targeted therapies. Especially the treatment of metastatic breast cancer poses even more challenges, as we still lose more than 42,000 women and men...

Descripción completa

Detalles Bibliográficos
Autores principales: Hobbs, Evthokia A., Chen, Natalie, Kuriakose, Alphi, Bonefas, Elizabeth, Lim, Bora
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9290149/
https://www.ncbi.nlm.nih.gov/pubmed/35860831
http://dx.doi.org/10.1177/17588359221112698

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9290149/
https://www.ncbi.nlm.nih.gov/pubmed/35860831
http://dx.doi.org/10.1177/17588359221112698

Ejemplares similares